Schoeneck James A
SEC insider (Form 3/4/5 filer). CIK 0001420987. Director at Calidi Biotherapeutics, Inc. (CLDI) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in SAN DIEGO,, CA.
Companies Schoeneck James A has filed insider reports for
- Calidi Biotherapeutics, Inc. (CLDI): Director
- KYNTRA BIO, INC. (KYNB): Director
- Connect Biopharma Holdings Ltd (CNTB): Director
Schoeneck James A
CIK: 0001420987
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Aug 17, 2026CLDI
Calidi Biotherapeutics, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
5K shares- - Jun 12, 2026KYNB
KYNTRA BIO, INC.
AwardDirectStock Option (Right to Buy)
7K shares- - Aug 21, 2025CLDI
Calidi Biotherapeutics, Inc.
PurchaseDirect75K shares at avg. $2.00$150K - Jul 9, 2025CLDI
Calidi Biotherapeutics, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
164.5K shares- - Jun 30, 2025FGEN
FIBROGEN INC
PurchaseIndirect23.6K shares at avg. $5.07$119K - Jun 4, 2025FGEN
FIBROGEN INC
AwardDirectStock Option (Right to Buy)
120K shares- - Mar 21, 2025FGEN
FIBROGEN INC
PurchaseIndirect50K shares at avg. $0.34$17K - Mar 20, 2025FGEN
FIBROGEN INC
PurchaseIndirect250K shares at avg. $0.35$88K - Sep 20, 2024CLDI
Calidi Biotherapeutics, Inc.
AwardDirectNon-Qualified Stock Options (right to buy)
20.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 |  CLDI Calidi Biotherapeutics, Inc. | Award Non-Qualified Stock Options (right to buy) | 5,000 | - | - | Direct |
| Jun 12, 2026 |  KYNB KYNTRA BIO, INC. | Award Stock Option (Right to Buy) | 7,000 | - | - | Direct |
| Aug 21, 2025 | CLDI Calidi Biotherapeutics, Inc. | Purchase | 75,000 | $2.00 | $150,000 | Direct |
| Jul 9, 2025 | CLDI Calidi Biotherapeutics, Inc. | Award Non-Qualified Stock Options (right to buy) | 164,493 | - | - | Direct |
| Jun 30, 2025 |  FGEN FIBROGEN INC | Purchase | 23,567 | $5.07 | $119,485 | Indirect |
| Jun 4, 2025 | FGEN FIBROGEN INC | Award Stock Option (Right to Buy) | 120,000 | - | - | Direct |
| Mar 21, 2025 | FGEN FIBROGEN INC | Purchase | 50,000 | $0.34 | $17,040 | Indirect |
| Mar 20, 2025 | FGEN FIBROGEN INC | Purchase | 250,000 | $0.35 | $88,000 | Indirect |
| Sep 20, 2024 | CLDI Calidi Biotherapeutics, Inc. | Award Non-Qualified Stock Options (right to buy) | 20,217 | - | - | Direct |
1-9 of 9 transactions